Variable | All participants (N = 42) |
---|---|
Sex, male/female (n) | 32/10 |
Age (years) (median (min–max)) | 72 (48–89) |
BMI (kg/m2) (median (min–max)) | 27 (14–57) |
Height (cm) (median (min–max)) | 170 (149–188) |
Weight (kg) (median (min–max)) | 74 (47–200) |
Primary pulmonary diagnosis | |
COPD (n) | 28 |
Fibrosis (n) | 12 |
Asbestos lung disease and pleural plaques (n) | 1 |
Alveolar hypoventilation (n) | 1 |
Oxygen therapy before ambulatory oxygen (yes/no) | 12/30 |
Assistive technology (yes/no) | 20/22 |
Cane/crutches/walker (n) | 18 |
Wheelchair (n) | 5 |
Comorbidities, ICD-10 group (median (min–max)) | 5 (1–10) |
IX: Cardiovascular (n) | 33 |
IV: Endocrine and metabolic (n) | 26 |
X: Other respiratory (n) | 19 |
XIII: Musculoskeletal (n) | 13 |
Other (II/VI/VII/VIII/XI/XII/XIV) (n) | 7/10/6/1/5/6/5 |
Education | |
Less than high school graduate (n) | 17 |
High school graduate (n) | 18 |
More than high school (n) | 7 |
Employed/Retired | 3/39 |
Smoking | |
Current (n) | 1 |
Former (n) | 34 |
Never (n) | 7 |
Smoking pack-years (median (min–max)) | 30 (2–150) |
Age of starting smoking (yrs.) | 20 (9–34) |
Mortality during the three-month follow-up (n) | 2 |